Skip to main content
BrainCited

Resveratrol pour Cerebrovascular Health

C

Research suggests resveratrol may improve cerebral blood flow through nitric oxide-mediated vasodilation and activation of neuroprotective SIRT1 pathways. Bioavailability remains a key challenge.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dresveratrol\u0026condition\u003Dcerebrovascular\u002Dhealth'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

En conclusion

Research suggests resveratrol may improve cerebral blood flow through nitric oxide-mediated vasodilation and activation of neuroprotective SIRT1 pathways. Bioavailability remains a key challenge.

Key Study Findings

Systematic Review
Investigating the impact of resveratrol and quercetin on glymphatic function, blood-brain barrier, and neuroglial health: …
Dose: None vs: None Outcome: effects on glymphatic function, BBB permeability, neuroglial health Effet: None None

Population: experimental models and clinical trials on Alzheimer's, Parkinson's, and multiple sclerosis

Review
Dietary Antioxidants, Polyphenols, and Vascular Health: Insights From Ultrasound Measurement of Carotid Intima-Media Thickness and …
Dose: None vs: None Outcome: None Effet: None None

Population: older adults and individuals with neurodegenerative disorders

In Vitro
Resveratrol attenuates the CoCl2-induced hypoxia damage by regulation of lysine β-hydroxybutyrylation in PC12 cells.
Dose: None vs: CoCl2-induced hypoxia without resveratrol Outcome: Cell viability and Kbhb modulation under hypoxia Effet: None None

Population: PC12 rat pheochromocytoma cells

Controlled Clinical Trial
[Verification of resveratrol ameliorating vascular endothelial damage in sepsis-associated encephalopathy through HIF-1α pathway based on …
Dose: 40 or 60 mg/kg vs: CLP group (0.9% NaCl) Outcome: Cerebrovascular endothelial barrier function Effet: None None

Population: CLP-induced sepsis-associated encephalopathy mice

Systematic Review
The Effects of Resveratrol on Menopausal Cardio-metabolic Changes: A Systematic Review.
Dose: None vs: Placebo or no treatment Outcome: Cardiometabolic changes in menopausal women Effet: None None

Population: Menopausal women

Key Statistics

8

Études

600

Participants

Positive

C

Note

Referenced Papers

International journal of … 2021 50 citations
Oxidative medicine and … 2017 87 citations
Integrative medicine research 2014 51 citations
Annals of the … 2013 31 citations
Ageing research reviews 2010 228 citations
Genes & nutrition 2010 64 citations
Journal of cardiovascular … 2009 297 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:
150-500 mg/day trans-resveratrol
cognitivesupport:
200-500 mg/day

Limite supérieure : 5,000 mg/day (highest dose in clinical trials)

Posologies étudiées dans la recherche

Posologie Durée Effet N
None -- Positive --
None -- Positive --
None -- Positive --
None -- Mixed --
40 or 60 mg/kg -- Positive --
None -- Positive --
None -- Mixed --
250 mg single dose -- Positive 16

Moment optimal de prise : With meals containing fat; morning preferred

Safety & Side Effects

Effets indésirables signalés

  • Gastrointestinal discomfort
  • Headache
  • Diarrhea at high doses

Interactions connues

  • Anticoagulants (may increase bleeding risk)
  • CYP450 substrates (affects drug metabolism)
  • Estrogen-sensitive conditions (weak estrogenic activity)

Apport maximal tolérable : 5,000 mg/day (highest dose in clinical trials)

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Resveratrol help with Cerebrovascular Health?
Based on 8 studies with 600 participants, there is limited but promising evidence that Resveratrol may support Cerebrovascular Health management. Our evidence grade is C (Some Evidence).
How much Resveratrol should I take for Cerebrovascular Health?
Studies have used various dosages. A commonly studied range is 150-500 mg/day trans-resveratrol. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Resveratrol?
Reported side effects may include Gastrointestinal discomfort, Headache, Diarrhea at high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Resveratrol and Cerebrovascular Health?
We rate the evidence as Grade C (Some Evidence). This rating is based on 8 peer-reviewed studies with 600 total participants. The overall direction of effect is positive.

Related Evidence

Autres ingrédients pour Cerebrovascular Health

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.